Sort
130,381 grants matching “hiv”
Role of integrins in HIV/SIV transmission across cervico-vaginal mucosa
$846,077Elena Martinelli · Population Council · R01 · FY2015 · AI
Development and application of a quantitive model for HIV-1 transcriptional activation driven by TAR RNA conformational dynamics
$846,046Hashim M Al-Hashimi · Columbia University Health Sciences · R01 · FY2023 · AI
Development of novel HIV Env vaccines to augment B lymphocyte responses via delivery of stabilized well-ordered Env spikes for comparative evaluation in preclinical immunogenicity and efficacy studies
$845,995Christopher Parks · International Aids Vaccine Initiative · P01 · FY2016 · AI
Structural study of the HIV1 gp41 coat protein
$845,991Ad Bax · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Human Papillomavirus (HPV) Genomics Project
$845,907Lisa Mirabello · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Using immune complex vaccines to optimize antibody responses to HIV Env
$845,905Catarina E Hioe · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AI
Development testing of nucleic acid-based vaccine for HIV other indications
$845,848Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
CAMPO Clinical Trials Program
$845,784Joel Palefsky · University Of California, San Francisco · U54 · FY2020 · CA
Mechanisms Underlying Persistent Lentivirus Replication in Follicular T Cells
$845,761Elizabeth Connick · University Of Colorado Denver · R01 · FY2015 · AI
Technology Based Community Health Nursing to Improve cART Adherence and Virologic Suppression in Youth Living with HIV (TechN 2 CheckIN): A Regional Multi-site Study
$845,751Allison L Agwu · Johns Hopkins University · R01 · FY2017 · MD
Role of the Orphan Receptors, LAIR-1,Toso and CD300, in Regulating Inflammation
$845,749John Coligan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Cytolytic antibodies:Bridging the gap between the innate and adaptive immune resp
$845,738Galit Alter · Massachusetts General Hospital · R01 · FY2012 · AI
Clinical Core
$845,697Frederick M Hecht · University Of California, San Francisco · P01 · FY2007 · AI
Developmental Core
$845,615Nevan J Krogan · University Of California, San Francisco · U54 · FY2025 · AI
MULTICENTER AIDS COHORT STUDY PATHOGENESIS RESEARCH LABS
$845,596University Of California Los Angeles · U01 · FY2001 · AI
Pooled and conventional nucleic acid testing strategies for SARS-CoV-2 to screen direct care research staff and protect HIV patients
$845,588Constance Ann Benson · University Of California, San Diego · UM1 · FY2020 · AI
SOUTHERN AFRICA-NEW YORK HIV VACCINE TRIALS UNIT
$845,499Medical Research Council Of South Africa · U01 · FY2003 · AI
Using immune complex vaccines to optimize antibody responses to HIV Env
$845,474Catarina E Hioe · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
Drug Abuse Treatment System Survey
$845,381University Of Michigan At Ann Arbor · R01 · FY2005 · DA
Project 2: Design and screening for immunogens to efficiently elicit anti-HIV-1 bNAbs
$845,350Pamela J Bjorkman · California Institute Of Technology · P01 · FY2020 · AI
HIV, Buprenorphine, and the Criminal Justice System
$845,338Frederick Lewis Altice · Yale University · R01 · FY2013 · DA
Longer-acting intravaginal formulation of buprenorphine
$845,335Thomas J. Smith · Auritec Pharmaceuticals, Inc. · R44 · FY2021 · DA
Longer-acting intravaginal formulation of buprenorphine
$845,335Thomas J. Smith · Auritec Pharmaceuticals, Inc. · R44 · FY2022 · DA
The Oral Mucosa in HIV Disease: Innate Immunity
$845,317Nina Agabian · University Of California, San Francisco · P01 · FY2007 · DE
Statistical methods and designs for correlated outcome and covariate errors in studies of HIV/AIDS
$845,194Bryan Earl Shepherd · Vanderbilt University Medical Center · R37 · FY2024 · AI